Status:
COMPLETED
Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine
Lead Sponsor:
Bradley Katz
Conditions:
Migraine Disorders
Photophobia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Approximately 9% of men and 18% of women suffer from migraine headaches. Almost all migraine sufferers report light sensitivity during a headache. Some people with migraine report that light can trigg...
Eligibility Criteria
Inclusion
- Must be diagnosed with migraine with aura or migraine without aura
- Must have chronic daily migraine (at least 15 headache days per month)
- Age 18 or older
Exclusion
- Currently wearing a spectacle tint specifically prescribed for migraine or light sensitivity
- Pregnant
- Unwilling or unable in the judgment of the investigator to complete the study
- Unavailable for any of the study visits
- Light sensitive conditions: meningitis, iritis, blepharospasm
- Degenerative diseases of the retina or optic nerve: diabetic retinopathy, ischemic optic neuropathy
- Medications known to affect retinal or optic nerve function: hydroxychloroquine, chloroquine, ethambutol, amiodarone, erectile dysfunction drugs
- Best corrected visual acuity less than 20/40 in either eye
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01828684
Start Date
March 1 2013
End Date
February 1 2014
Last Update
March 31 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
John A Moran Eye Center; University of Utah Hospitals and Clinics
Salt Lake City, Utah, United States, 84132